These results provide evidence of the effectiveness of siRNA in reducing MTNR1B expression and its potential utility as a tool for studying the function of this gene in experimental models related to metabolic disorders, such as obesity and type 2 diabetes. Here, MTNR1B is linked to metabolic disease.